China Lifesciences Update and Predictions for 2017
2016 saw important legal news and developments in the Lifesciences sector in China and we have produced the ‘China Lifesciences Update and Predictions for 2017’ capturing the highlights, including the anti-trust investigations, publication of new policies and procedures and confirmation by the CFDA on the completion of the legal framework for food and drug regulation by 2020.
We also look ahead to 2017 and predicted developments, including tightened supervision on anti-bribery, the new drug price regime, details on the implementation measures on the registration of biosimilars and the reform in social insurance, M-health and the medical industry.
We will continue to monitor the legal news and developments in the Lifesciences sector in China for you and provide you with regular updates through Law-Now.
We hope you find this update interesting and informative and if you have any questions, please do let us know.